Apoptin gene transfer via modified wheat histone H4 facilitates apoptosis of human ovarian cancer cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 1, 2011, Pages 121-126

  Wang, Chunyan ^a   Zhang, Yujing ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

apoptosis; cell therapy; gene transfer; targeted therapy

Indexed keywords

APOPTIN; HISTONE H4; MESSENGER RNA; PLASMID DNA;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NONVIRAL GENE DELIVERY SYSTEM; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

APOPTOSIS; CAPSID PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HISTONES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; OVARIAN NEOPLASMS; PLASMIDS; TRANSFECTION; TRITICUM;

EID: 79952146216     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2010.0858     Document Type: Article

References (32)

1. Balicki D, Beutler E. Histone H2A significantly enhances in vitro DNA transfection. Mol Med 1997;3:782.
2. Puebla I, Esseghir S, Mortlock A, et al. A recombinant H1 histone-based system for efficient delivery of nucleic acids. J Biotechnol 2003;105:215.
3. Wagstaff KM, Fan JY, De Jesus MA, et al. Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting. FASEB J 2008;22:2232.
4. Wagstaff KM, Glover DJ, Tremethick DJ, et al. Histone-mediated transduction as an efficient means for gene deliv-ery. Mol Ther 2007;15:721.
5. Zaitsev S, Buchwalow I, Haberland A, et al. Histone H1-mediated transfection: Role of calcium in the cellular uptake and intracellular fate of H1-DNA complexes. Acta Histochem 2002;10485.
6. Baake M, Doenecke D, Albig W. Characterisation of nuclear localisation signals of the four human core histones. J Cell Biochem 2001;81:333.
7. Tabata T, Sasaki K, Iwabuchi M. The structural organization and DNA sequence of a wheat histone H4 gene. Nucleic Acids Res 1983;11:5865.
8. Al-Taei S, Penning NA, Simpson, JC, et al. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjug Chem 2006;17:90.
9. Fittipaldi A, Giacca M. Transcellular protein transduction using the Tat protein of HIV-1. Adv Drug Deliv Rev 2005;57: 597.
10. Wadia JS, Dowdy SF. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduc-tion in the treatment of cancer. Adv Drug Deliv Rev 2005; 57:579.
11. Dharap SS, Wang Y, Chandna P, et al. Tumor-specific tar-geting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA 2005;102:12962.
12. Grundker C, Gunthert AR, Millar RP, et al. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. J Clin Endocrinol Metab 2002;87:1427.
13. Völker P, Gründker C, Schmidt O, et al. Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, auto-regulation, and correlation with direct antiproliferative ac-tivity of luteinizing hormone-releasing hormone analogues* 1. Am J Obstet Gynecol 2002;186:171.
14. Oorschot A, Fischer DF, Grimbergen JM, et al. Apoptin in-duces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 1997; 94:5843.
15. Oro C, Jans DA. The tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virus. Curr Drug Tar-gets 2004;5:179.
16. Poon IKH, Oro C, Dias MM, et al. A tumor cell-specific nuclear targeting signal within chicken anemia virus VP3/apoptin. J Virol 2005;79:1339.
17. Guelen L, Paterson H, Gäken J, et al. TAT-apoptin is effi-ciently delivered and induces apoptosis in cancer cells. On-cogene 2003;23:1153.
18. Lee YH, Cheng CM, Chang YF, et al. Apoptin T108 phos-phorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Bio-chem Biophys Res Commun 2007;354:391.
19. Rohn JL, Zhang YH, Leliveld SR, et al. Relevance of Apop-tin's integrity for its functional behavior. J Virol 2005;79: 1337.
20. Los M, Panigrahi S, Rashedi I, et al. Apoptin, a tumor-selective killer. Biochim Biophys Acta 2009;1793:1335.
21. Maddika S, Booy EP, Johar D, et al. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 2005;118:4485.
22. Emaus RK, Grunwald R, Lemasters JJ. Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mi-tochondria: Spectral and metabolic properties. Biochim Biophys Acta 1986;850:436.
23. Millot JM, Sharonov S, Manfait M. Scanning microspectro-fluorometry of rhodamine 123 in multidrug-resistant cells. Cytometry Part A 2005;17:50.
24. Budker V, Hagstrom JE, Lapina O, et al. Protein/amphipathic polyamine complexes enable highly efficient transfection with minimal toxicity. Biotechniques 1997;23: 139.
25. Zaitsev SV, Haberland A, Otto A, et al. H1 and HMG17 extracted from calf thymus nuclei are efficient DNA carriers in gene transfer. Gene Ther 1997;4:586.
26. Del Bello B, Valentini MA, Mangiavacchi P, et al. Role of caspases-3 and-7 in Apaf-1 proteolytic cleavage and degra-dation events during cisplatin-induced apoptosis in mela-noma cells. Exp Cell Res 2004;293:302.
27. Scaduto RC, Grotyohann LW. Measurement of mitochon-drial membrane potential using fluorescent rhodamine de-rivatives. Biophys J 1999;76:469.
28. Antonsson B, Martinou JC The Bcl-2 protein family. Exp Cell Res 2000;256:50.
29. Hill MM, Adrain C, Martin SJ. Portrait of a killer: The mi-tochondrial apoptosome emerges from the shadows. Mol Interv 2003;3:19.
30. Maddika S, Mendoza FJ, Hauff K, et al. Cancer-selective therapy of the future: Apoptin and its mechanism of action Cancer Biol Ther 2006;5:10.
31. Martinou JC, Desagher S, Antonsson B. Cytochrome c re-lease from mitochondria: All or nothing. Nat Cell Biol 2000;2:E41.
32. Renz A, Berdel WE, Kreuter M, et al. Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood 2001;98:154.